Sanofi Consumer Healthcare India Limited — Board Meeting, 04-08-2025: Outcome of Board Meeting

Sanofi Consumer Healthcare India's board has approved the financial results for the quarter and half-year ended June 30, 2025. For the quarter, revenue surged to ₹220.9 Cr, with net profit standing strong at ₹60.7 Cr. Half-year revenue reached ₹393.5 Cr, and net profit was ₹110.7 Cr. Profit was boosted by a ₹6.6 Cr exceptional gain from reversing demerger provisions. The company successfully re-launched Depura Adult and Combiflam Suspension. Notably, the ultimate parent company has changed to Opal JVco S.a.r.l, a significant development following Sanofi's global stake sale. #SanofiIndia #Earnings